Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Replimune Group, Inc. Director's Dealing 2026

Feb 20, 2026

33193_dirs_2026-02-20_17098ae5-f178-44b5-b102-fb88fc6c4f23.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2026-02-18

Reporting Person: Astley-Sparke Philip (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2026-02-18 Common Stock G 25000 Disposed 1380071 Direct